Pulmonary Disease Clinical Trials in Washington D.C., District of Columbia
3 recruitingWashington D.C., District of Columbia
Showing 1–3 of 3 trials
Recruiting
Phase 3
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Chronic Obstructive Pulmonary Disease
Sanofi942 enrolled213 locationsNCT07190222
Recruiting
Phase 3
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD, Chronic Obstructive Pulmonary Disease
AstraZeneca5,000 enrolled920 locationsNCT06283966
Recruiting
Cooperative Assessment of Late Effects for SCD Curative Therapies
Sickle Cell DiseaseHeart DiseasePulmonary Disease+1 more
Vanderbilt University Medical Center750 enrolled5 locationsNCT05153967